These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 29505199)

  • 1. Prep for Latinx Communities.
    Almanza K
    Posit Aware; 2016; 28(6):28-9. PubMed ID: 29505199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engaging a Predominantly Latino Community in HIV Prevention: Laying the Groundwork for Pre-exposure Prophylaxis and HIV Sexual Health Programs.
    Carnevale C; Zucker J; Borsa A; Northland B; Castro J; Molina E; Richards P; Dominguez J; George W; Cohall A; Olender S; Gordon P; Sobieszczyk ME
    J Assoc Nurses AIDS Care; 2020; 31(1):92-97. PubMed ID: 31498165
    [No Abstract]   [Full Text] [Related]  

  • 3. Vital Signs: Increased Medicaid Prescriptions for Preexposure Prophylaxis Against HIV infection--New York, 2012-2015.
    Laufer FN; O'Connell DA; Feldman I; ; Zucker HA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1296-301. PubMed ID: 26606257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
    Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
    Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing HIV Infection-What Pediatricians Should Know About HIV Pre-Exposure Prophylaxis.
    Fernandez S
    Pediatr Ann; 2018 Jan; 47(1):e2-e4. PubMed ID: 29323688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PrEP Forum: an on-line debate on pre-exposure prophylaxis in Brazil].
    Queiroz AAFLN; Sousa AFL
    Cad Saude Publica; 2017 Nov; 33(11):e00112516. PubMed ID: 29166481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples.
    Hoff CC; Chakravarty D; Bircher AE; Campbell CK; Grisham K; Neilands TB; Wilson PA; Dworkin S
    AIDS Patient Care STDS; 2015 Jul; 29(7):408-17. PubMed ID: 26057304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PrEP, Truvada, and Gilead.
    Jack A
    BMJ; 2016 Sep; 354():i4800. PubMed ID: 27609216
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV Pre-Exposure prophylaxis (PrEP) in men].
    Spinner CD
    MMW Fortschr Med; 2017 Jun; 159(Suppl 2):40-42. PubMed ID: 28597265
    [No Abstract]   [Full Text] [Related]  

  • 11. The Transition From Postexposure Prophylaxis to Preexposure Prophylaxis: An Emerging Opportunity for Biobehavioral HIV Prevention.
    Jain S; Krakower DS; Mayer KH
    Clin Infect Dis; 2015 Jun; 60 Suppl 3(Suppl 3):S200-4. PubMed ID: 25972505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-based pre-exposure prophylaxis (PrEP) services for gay and bisexual men: An opportunity to address barriers to PrEP uptake and persistence.
    John SA; Rendina HJ; Grov C; Parsons JT
    PLoS One; 2017; 12(12):e0189794. PubMed ID: 29281688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-exposure prophylaxis (PrEP) for men who have sex with men in Europe: review of evidence for a much needed prevention tool.
    Reyniers T; Hoornenborg E; Vuylsteke B; Wouters K; Laga M
    Sex Transm Infect; 2017 Aug; 93(5):363-367. PubMed ID: 27872326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015.
    Smith DK; Van Handel M; Wolitski RJ; Stryker JE; Hall HI; Prejean J; Koenig LJ; Valleroy LA
    MMWR Morb Mortal Wkly Rep; 2015 Nov; 64(46):1291-5. PubMed ID: 26606148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How many MSM are taking PrEP: a service evaluation.
    Whitlock GG; Douglas A; Adesara S; McCormack S; Nwokolo N; McOwan A
    Sex Transm Infect; 2017 Nov; 93(7):529. PubMed ID: 29061697
    [No Abstract]   [Full Text] [Related]  

  • 19. Being PrEPared - Preexposure Prophylaxis and HIV Disparities.
    Goldstein RH; Streed CG; Cahill SR
    N Engl J Med; 2018 Oct; 379(14):1293-1295. PubMed ID: 30230965
    [No Abstract]   [Full Text] [Related]  

  • 20. Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.
    Auerbach JD; Kinsky S; Brown G; Charles V
    AIDS Patient Care STDS; 2015 Feb; 29(2):102-10. PubMed ID: 25513954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.